Stock Track | Pharmaron Plummets 5.10% Intraday Amid Shareholder Reduction Plans and Sector Weakness

Stock Track05-05

Pharmaron's stock plummeted 5.10% intraday, weighed down by planned share sales from major shareholders and broad declines across the life sciences sector.

The decline follows recent disclosures that shareholders Xinzhong Kangcheng and its concert party Xinzhong Longcheng plan to reduce holdings by up to 27.56 million shares, representing approximately 1.50% of total share capital, within three months starting May 27. Additionally, Longtai Zhongxin, a concert party of co-founder Zheng Bei, plans to sell up to 1.33 million shares. The combined planned reduction totals about 1.57% of outstanding shares, creating an overhang on the stock.

The selling pressure coincides with weakness across the life sciences tools and services sector, with peers including Wuxi Biologics, Wuxi AppTec, Wuxi XDC, and Insilico also trading lower during the session.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment